当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第19期
编号:11620932
丙丁酚对高脂血症小鼠表达C反应蛋白的影响(3)
http://www.100md.com 2008年7月22日 《中国实用医药》 2008年第19期
     参考文献

    [1] Gortney JS,Sanders RM.Impact of C-reactive protein on treatment of patients with cardiovascular disease.Am J Health Syst Pharm,2007,64(19):2009-2016.

    [2] Ridker PM.High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.Circulation,2001,103(13):1813-1818.

    [3] Tagawa T,Urabe Y,Kimura Y,et al.Long-term treatment with probucol improves endothelial function in patients with coronary artery disease.Hypertens Res,2004,27:311-318.

    [4] Blake GJ,Ridker PM.Novel clinical markers of vascular wall inflammation.Circ Res,2001,89:763-771.

    [5] Aarnisalo AA,Aalto-Setala K,Holthofer H,et al.Puromycin-induced lipid peroxidation in the cochlea of ApoE knockout mice.Acta Otolaryngol(Suppl).2000,543:102-105.

    [6] 刘晓,吴雨基.C反应蛋白与动脉粥样硬化性脑卒中.中国实用医药,2007,2(6):29-30.

    [7] Packard RR,Libby P.Inflammation in atherosclerosis:from vascular biology to biomarker discovery and risk prediction.Clin Chem,2008,54(1):24-38.

    [8] 张慧平,孙福成,季福绥,等.C-反应蛋白与冠心病关系的研究.心血管康复医学杂志,2007,16(3):223-225.

    [9] Haverkate F,Thompson SG,Pyke SD,et al.Production of C-reactive protein and risk of coronary events in stable and unstable angina.Lancet.1997,349(9050):462-466., 百拇医药(叶延平 李 良 莫中成 龙治峰 石金凤 尹小波 李 霞 易光)
上一页1 2 3